Skip to main content
Veterinary Medicines

Tetra-Delta (105 mg + 100 000 j.m. + 100 mg + 100 mg + 10 mg) /10 ml Zawiesina dowymieniowa

Not authorised
  • Prednisolone
  • Benzylpenicillin procaine
  • Dihydrostreptomycin sulfate
  • Neomycin
  • Novobiocin sodium

Product identification

Medicine name:
Tetra-Delta (105 mg + 100 000 j.m. + 100 mg + 100 mg + 10 mg) /10 ml Zawiesina dowymieniowa
Active substance:
  • Prednisolone
  • Benzylpenicillin procaine
  • Dihydrostreptomycin sulfate
  • Neomycin
  • Novobiocin sodium
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Prednisolone
    10.00
    milligram(s)
    /
    10.00
    millilitre(s)
  • Benzylpenicillin procaine
    100000.00
    international unit(s)
    /
    1.00
    international unit(s)
  • Dihydrostreptomycin sulfate
    100.00
    milligram(s)
    /
    10.00
    millilitre(s)
  • Neomycin
    105.00
    milligram(s)
    /
    10.00
    millilitre(s)
  • Novobiocin sodium
    100.00
    milligram(s)
    /
    10.00
    millilitre(s)
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        5
        week
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RV01
Authorisation status:
  • Surrendered
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Polska Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
  • Norbrook Laboratories Limited
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 0259
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."